Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3/5
Grifols (GRFS US)
Watchlist
Contact IR
30
Analysis
Health Care
•
Spain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
Watchlist
Contact IR
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Volkswagen (Pref)
•
16 Oct 2024 12:13
Liquid Universe of European Ordinary and Preferred Shares: October‘24 Report
Since mid-September, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (9 have...
Jesus Rodriguez Aguilar
Follow
449 Views
Share
bullish
•
Grifols SA
•
20 Sep 2024 16:30
Brookfield/Grifols: Recap and Analysis of Latest Developments
Since Brookfield's July 8 takeover interest for Grifols was announced, the situation has become complicated, with unclear pricing, funding...
Jesus Rodriguez Aguilar
Follow
479 Views
Share
bullish
•
Henkel & KGaA
•
17 Sep 2024 15:58
Liquid Universe of European Ordinary and Preferred Shares: September‘24 Report
Since mid-August, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (13 have...
Jesus Rodriguez Aguilar
Follow
345 Views
Share
bullish
•
Grifols SA
•
30 Aug 2024 13:15
Brookfield Explores Sovereign Funds for Grifols Takeover Bid
Press reports Brookfield is seeking support from sovereign wealth funds, including those from Abu Dhabi (ADQ) and Singapore (GIC), to back its bid,...
Jesus Rodriguez Aguilar
Follow
355 Views
Share
bullish
•
Grifols SA
•
22 Aug 2024 21:45
Brookfield/Grifols: Update & Recap, Spread, Discount
Bloomberg reported that Brookfield (BN CN) is seeking bank backing for up to €9.5 billion in debt to facilitate a potential take-private...
Jesus Rodriguez Aguilar
Follow
489 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.5
x